Medical device safety and effectiveness remain challenging principles to define and enforce.
News & Features
A lawyer representing former MiMedx CEO and COO says the executives were the victims of an "unfortunate practice" among public companies.
During TCT, the Marlborough, MA-based company revealed results of the IMPERIAL study, which showed its Eluvia stent performed significantly better than Cook Medical’s Zilver PTX.
With TCT in full swing, Or Yehuda, Israel-based Cardiovalve is launching the AHEAD US Multicenter Study, and jumping head first into the quickly growing TMVR market.
Presenters at MD&M Minneapolis will discuss how using technologies from other industries can make medical device manufacturing more efficient.
A new brace targets Achilles tendonitis, plantar fasciitis, and more than 30 other foot and ankle disorders.
More than two years after Medtronic first hitched its wagon to Mazor Robotics, the pair is making it official through an acquisition valued at $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired.
The Menlo Park, CA-based company said it has raised $10 million in a series B to help support a clinical study of its technology.
InTouch Health is building an Internet of Medical Things for Intuitive Surgical that could also benefit other medical device companies and healthcare systems.
Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.
Two separate studies show how researchers are using machine learning to train computers to spot and classify cells just by analyzing medical images.
Quadrant Biosciences scored a $2 million NIH grant to supports its epigenetic diagnostic test for autism spectrum disorder.